Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Teppei Okubo"'
Publikováno v:
IJU Case Reports, Vol 3, Iss 6, Pp 261-264 (2020)
Introduction Mucinous urethral adenocarcinoma is a rare and progressive cancer of the prostatic urethra. Reports on palliative systemic treatment for mucinous urethral adenocarcinoma are few. We present a case of coexisting mucinous urethral and pros
Externí odkaz:
https://doaj.org/article/907fa688315f42b191ca45bb066d2a24
Publikováno v:
IJU Case Reports
IJU Case Reports, Vol 3, Iss 6, Pp 261-264 (2020)
IJU Case Reports, Vol 3, Iss 6, Pp 261-264 (2020)
Introduction Mucinous urethral adenocarcinoma is a rare and progressive cancer of the prostatic urethra. Reports on palliative systemic treatment for mucinous urethral adenocarcinoma are few. We present a case of coexisting mucinous urethral and pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f9adecf1993b0c9bded3a83f17ce1c
http://europepmc.org/articles/PMC7609175
http://europepmc.org/articles/PMC7609175
Autor:
Takatoshi Kaya, Kazuyuki Mori, Tohru Yoneyama, Yoshihiko Suda, Tomonori Kaneko, Jehonathan H. Pinthus, Yasuhiro Hashimoto, Yuki Tobisawa, Chikara Ohyama, Wilhelmina C.M. Duivenvoorden, Shingo Hatakeyama, Koji Mitsuzuka, Takuya Koie, Robert A. Gardiner, Teppei Okubo, Mihoko Sutoh Yoneyama, Akihiro Ito
Publikováno v:
Cancer Science
To reduce unnecessary prostate biopsies (Pbx), better discrimination is needed. To identify clinically significant prostate cancer (CSPC) we determined the performance of LacdiNAc‐glycosylated prostate‐specific antigen (LDN‐PSA) and LDN‐PSA n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b31de959a42ec21bc78e3f8b37441f8
https://doi.org/10.1111/cas.14082
https://doi.org/10.1111/cas.14082
Autor:
Yoichi Arai, Tatsuo Tochigi, Takuya Koie, Koji Mitsuzuka, Chikara Oyama, Atsushi Koizumi, Akihiro Ito, Shintaro Narita, Yoshinori Matsuda, Sadafumi Kawamura, Shingo Hatakeyama, Tomonori Habuchi, Teppei Okubo
Publikováno v:
Annals of surgical oncology. 28(9)
This study was designed to assess the relationship between nerve-sparing (NS) status, positive surgical margin (PSM) location, and biochemical recurrence (BCR) based on a multicenter, radical prostatectomy (RP) database. We retrospectively reviewed d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395df569a4c1453a6771531591364739
https://pubmed.ncbi.nlm.nih.gov/34109511
https://pubmed.ncbi.nlm.nih.gov/34109511
Autor:
Teppei Okubo, Koji Mitsuzuka, Paula M. Vertino, Yuriko Saiki, Toshiya Miyauchi, Masahiro Takahashi, Akiteru Goto, Shinichi Fukushige, Akira Horii, Yoichi Arai
Publikováno v:
Disease Markers
Disease Markers, Vol 2021 (2021)
Disease Markers, Vol 2021 (2021)
Epigenetic gene silencing by aberrant DNA methylation leads to loss of key cellular pathways in tumorigenesis. In order to analyze the effects of DNA methylation on prostate cancer, we established LNCaP-derived human prostate cancer cells that can ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cb3222075537e3a40c564e25debfbbb
https://pubmed.ncbi.nlm.nih.gov/33628338
https://pubmed.ncbi.nlm.nih.gov/33628338
Autor:
Kazuyuki Mori, M. Sutoh Yoneyama, Jehonathan H. Pinthus, M. Date, Robert A. Gardiner, Chikara Ohyama, Tohru Yoneyama, Teppei Okubo, Yuki Tobisawa, Shingo Hatakeyama, Koji Mitsuzuka, Akihiro Ito, Takuya Koie, Takatoshi Ishikawa, Yasuhiro Hashimoto, Wilhelmina C.M. Duivenvoorden
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e510-e511 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::535a8fe66587f7319b09242a9e4fbfdc
http://www.sciencedirect.com/science/article/pii/S2666168320329062
http://www.sciencedirect.com/science/article/pii/S2666168320329062
Autor:
Yasuhiro Hashimoto, Mihoko Sutoh Yoneyama, Akihiro Ito, Chikara Ohyama, Robert A. Gardiner, Koji Mitsuzuka, Takuya Koie, Takatoshi Kaya, Wilhelmina C.M. Duivenvoorden, Teppei Okubo, Yuki Tobisawa, Jehonathan H. Pinthus, Shingo Hatakeyama, Tohru Yoneyama, Kazuyuki Mori, Tomonori Kaneko
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:To reduce unnecessary prostate biopsies (Pbx), better discrimination is needed. To identify significant prostate cancer (sigPC) we determined the performance of LacdiNAc-...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::423c8665358609606f96c19da1eeda66
https://doi.org/10.1097/ju.0000000000000954.010
https://doi.org/10.1097/ju.0000000000000954.010
Autor:
Shintaro Narita, Yoshinori Matsuda, Chikara Ohyama, Sadafumi Kawamura, Takuya Koie, Koji Mitsuzuka, Tomonori Habuchi, Tatsuo Tochigi, Shingo Hatakeyama, Atsushi Koizumi, Teppei Okubo, Yoichi Arai
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:The impact of a positive surgical margin (PSM) considering the nerve-sparing status on clinical outcomes in patients with prostate cancer treated with radical prostatect...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84376a31677dfd582db3177e0227a1de
https://doi.org/10.1097/01.ju.0000556540.84319.67
https://doi.org/10.1097/01.ju.0000556540.84319.67
Autor:
Tohru Yoneyama, Yuki Tobisawa, Tomokazu Ishikawa, Shingo Hatakeyama, Kazuyuki Mori, Mihoko Sutoh Yoneyama, Teppei Okubo, Koji Mitsuzuka, Wilhelmina Duivenvoorden, Jehonathan H. Pinthus, Yasuhiro Hashimoto, Akihiro Ito, Takuya Koie, Mutsuhiro Date, Robert A. Gardiner, Chikara Ohyama
Publikováno v:
The Journal of Urology. 203:e1099
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88006dd39245e37ef0f278ce55220737
https://doi.org/10.1097/ju.0000000000000955.07
https://doi.org/10.1097/ju.0000000000000955.07
Autor:
Koji Mitsuzuka, Chikara Ohyama, Tomonori Habuchi, Norihiko Tsuchiya, Senji Hoshi, Yoichi Arai, Shigeki Matsuo, Takuya Koie, Seiichi Saito, Teppei Okubo
Publikováno v:
Japanese journal of clinical oncology. 48(6)
Background Salvage treatments for biochemical relapse (BCR) after radical prostatectomy (RP) have several problems in terms of indications or adverse events. We studied the possibility of 2 years of bicalutamide monotherapy for BCR after RP. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12a0771fcc3c0e870469b63a1b2d873
https://pubmed.ncbi.nlm.nih.gov/29718346
https://pubmed.ncbi.nlm.nih.gov/29718346